I did a two year comparison of ARX with Nuvista (Q3 '21 to Q3 '23). ARX grew less than 2%. Nuvista grew from 51,000 to 80,000 boepd almost 60% growth. Nuvista condensate grew from 15,779 to 26,704 boepd. Shareholder returns - buybacks and debt reduction - more or less the same using 4.5X (ending) production factor (guess of $616M vs $2.7B). Of course ARX started off 7X larger than NVA...Only thing is ARX pays a dividend, NVA doesn't. Is it the play, management or a bit of both? I don't know.
Draw your own conclusions.
Well almost a full year later here are the conclusions:
ARX shareprice YTD 2024 +26%
NVA shareprice YTD 2024 +16%